Investing.com -- Les actions d'Allurion Technologies (NYSE: ALUR) ont bondi de 350% suite à l'annonce par la société de son intention de lancer une étude clinique visant à optimiser la masse ...
6d
-- Allurion Technologies a déclaré vendredi avoir signé un accord définitif avec certains investisseurs institutionnels pour ...
La nouvelle ligne 211GO reliera Ballon-Saint-Mars au pôle d’échange multimodal Maillets-Zamenhof. Assurant quotidiennement sept allers-retours... Il était une fois en l’an 2001, l’ASL et ...
Allurion Technologies shares soared 200% Friday as it planned to test its gastric balloon with the key ingredient in popular weight-loss drugs to see if the combination improves patients' muscle mass.
NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (“Allurion” or the “Company”) (NYSE: ALUR), a company dedicated to ending obesity, today announced that it has entered into a ...
09:36 EST Allurion Technologies (ALUR) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news.
Shares of Allurion Technologies (ALUR, Financials) surged 80.5% in after-hours trading on Thursday, closing at $6.68 as of 7:59 p.m. GMT-5. The company's announcement of intentions for a clinical ...
Allurion Technologies (NYSE:ALUR) climbed 200% in the morning hours on Friday, adding to its strong post-market gains yesterday, even after the weight loss product developer announced plans to ...
The company plans to evaluate its Allurion Program with GLP-1 agonists to address muscle loss concerns and promote healthier weight loss. Allurion entered into a securities purchase agreement to ...
NATICK, Mass., January 24, 2025--(BUSINESS WIRE)--Allurion Technologies, Inc. ("Allurion" or the "Company") (NYSE: ALUR), a company dedicated to ending obesity, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback